ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 7 filers reported holding ENLIVEX THERAPEUTICS LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,658,000 | -31.7% | 331,001 | -23.8% | 0.01% | 0.0% |
Q1 2022 | $2,428,000 | +11.2% | 434,343 | +24.3% | 0.01% | +42.9% |
Q4 2021 | $2,183,000 | -51.7% | 349,308 | -23.7% | 0.01% | -36.4% |
Q3 2021 | $4,523,000 | -1.3% | 457,797 | -11.1% | 0.01% | +22.2% |
Q2 2021 | $4,582,000 | -13.3% | 514,807 | +8.1% | 0.01% | -10.0% |
Q1 2021 | $5,283,000 | +1535.6% | 476,414 | +1136.3% | 0.01% | +25.0% |
Q4 2019 | $323,000 | – | 38,536 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 82,500 | $735,000 | 0.38% |
Golden Green, Inc. | 46,020 | $410,000 | 0.31% |
ARK Investment Management | 514,807 | $4,582,000 | 0.01% |
Compagnie Lombard Odier SCmA | 25,000 | $220,000 | 0.01% |
Banque Cantonale Vaudoise | 10,000 | $89,000 | 0.00% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 13,000 | $116,000 | 0.00% |
Renaissance Technologies | 195,706 | $1,742,000 | 0.00% |
Steward Partners Investment Advisory, LLC | 15,500 | $136,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 897 | $8,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 19,491 | $174,000 | 0.00% |